Search Results - "Markus, Henry Z"

Human Papillomavirus Type 11 (HPV-11) Neutralizing Antibodies in the Serum and Genital Mucosal Secretions of African Green Monkeys Immunized with HPV-11 Virus-like Particles Expressed in Yeast by Lowe, Robert S., Brown, Darron R., Bryan, Janine T., Cook, James C., George, Hugh A., Hofmann, Kathryn J., Hurni, William M., Joyce, Joseph G., Lehman, E. Dale, Markus, Henry Z., Neeper, Michael P., Schultz, Loren D., Shaw, Alan R., Jansen, Kathrin U.

“…It has been shown previously that immunization of animals with recombinant virus-like particles (VLPs) consisting of the viral capsid proteins L1 or L1 plus L2…”
Get full text

Sequence conservation within the major capsid protein of human papillomavirus (HPV) type 18 and formation of HPV-18 virus-like particles in Saccharomyces cerevisiae by Hofmann, Kathryn J, Neeper, Michael P, Markus, Henry Z, Brown, Darron R, Muller, Martin, Jansen, Kathrin U

“…1 Department of Virus and Cell Biology, Merck Research Laboratories, Sumneytown Pike, West Point, Pennsylvania 19486 2 Division of Infectious Diseases, Indiana…”
Get full text

Vaccination with yeast-expressed cottontail rabbit papillomavirus (CRPV) virus-like particles protects rabbits from CRPV-induced papilloma formation by Jansen, Kathrin U., Rosolowsky, Mark, Schultz, Loren D., Markus, Henry Z., Cook, James C., Donnelly, John J., Martinez, Douglas, Ellis, Ronald W., Shaw, Alan R.

“…Papillomaviruses infect epithelia of the skin and mucous membranes and cause benign or malignant tumours in animals and in humans. The viruses are highly…”
Get full text

Stabilized Measles Vaccine in a Novel Single-Dose Delivery System: A Practical Reality for Worldwide Elimination of Measles by Hilleman, Maurice R., William J. Mc Aleer, Arlene A. Mc Lean, Eugene B. Buynak, Henry Z. Markus

“…A live measles virus vaccine that is highly temperature-stable and dispensed in an inexpensive syringe is described. This configuration should prove useful for…”
Get full text

Using molecular genetics to improve the production of recombinant proteins by the yeast Saccharomyces cerevisiae by Schultz, L D, Markus, H Z, Hofmann, K J, Montgomery, D L, Dunwiddie, C T, Kniskern, P J, Freedman, R B, Ellis, R W, Tuite, M F

Get more information

Expression and Purification of Recombinant Tick Anticoagulant Peptide (Y1W/D10R) Double Mutant Secreted bySaccharomyces cerevisiae by Cook, James C., Schultz, Loren D., Huang, Jin, George, Hugh A., Herber, Wayne K., Ip, Charlotte, Joyce, Joseph G., Mao, Shi-Shan, Markus, Henry Z., Miller, William J., Sardana, Mohinder K., Lehman, E.Dale

“…A double mutant of tick anticoagulant peptide (TAP) was cloned as a chimeric fusion with the yeast α-mating factor pre-proleader peptide. Expression in yeast…”
Get full text

Expression and purification of recombinant tick anticoagulant peptide (Y1W/D10R) double mutant secreted by Saccharomyces cerevisiae by Cook, J C, Schultz, L D, Huang, J, George, H A, Herber, W K, Ip, C, Joyce, J G, Mao, S S, Markus, H Z, Miller, W J, Sardana, M K, Lehman, E D

“…A double mutant of tick anticoagulant peptide (TAP) was cloned as a chimeric fusion with the yeast alpha-mating factor pre-proleader peptide. Expression in…”
Get full text

Expression, purification and characterization of multigram amounts of a recombinant hybrid HV1-HV2 hirudin variant expressed in Saccharomyces cerevisiae by Lehman, E D, Joyce, J G, Bailey, F J, Markus, H Z, Schultz, L D, Dunwiddie, C T, Jacobson, M A, Miller, W J

“…Hirudin (HIR), derived from leeches, and tick anticoagulant peptide (TAP) are polypeptide protease inhibitors of thrombin and coagulation factor Xa (fXa),…”
Get more information

Purification and characterization of human plasminogen activator inhibitor type I expressed in Saccharomyces cerevisiae by Gardell, S J, Hare, T R, Han, J H, Markus, H Z, Keech, B J, Carty, C E, Ellis, R W, Schultz, L D

“…The rapidly acting inhibitor of plasminogen activators, PAI-1, was produced intracellularly in Saccharomyces cerevisiae by using the ADH2 promoter to drive the…”
Get more information

Characterization of recombinant antistasin secreted by Saccharomyces cerevisiae by Przysiecki, C T, Joyce, J G, Keller, P M, Markus, H Z, Carty, C E, Hagopian, A, Sardana, M K, Dunwiddie, C T, Ellis, R W, Miller, W J

“…Secretion from recombinant yeast was used as a potential source of large quantities of the leech protein antistasin (ATS), a potent and highly specific…”
Get more information

Vaccine against human hepatitis B virus prepared from antigen derived from human hepatoma cells in culture by McAleer, W J, Markus, H Z, Wampler, D E, Buynak, E B, Miller, W J, Weibel, R E, McLean, A A, Hilleman, M R

“…Vaccine against human hepatitis B was prepared using antigen derived from hepatitis B carrier hepatoma cells grown in the interstices of a Diaflo hollow filter…”
Get more information

Production of purified hepatitis B surface antigen from Alexander hepatoma cells grown in artificial capillary units by McAleer, W J, Markus, H Z, Bailey, F J, Herman, A C, Harder, B J, Wampler, D E, Miller, W J, Keller, P M, Buynak, E B, Hilleman, M R

“…An artificial capillary system was devised for growth of hepatoma cells that yields very high titers of hepatitis B surface antigen (HBsAg). High yield of…”
Get more information

Stability on storage at various temperatures of live measles, mumps and rubella virus vaccines in new stabilizer by McAleer, W J, Markus, H Z, McLean, A A, Buynak, E B, Hilleman, M R

Get more information